HUTCHMED (China) (HCM) Change in Inventory (2020 - 2021)

HUTCHMED (China)'s (HCM) quarterly Change in Inventory came in at -$64000.0 in Q1 2021, up 85.32% year-on-year from -$34534.7 in Q1 2020, and up 85.32% on a QoQ basis from -$436000.0 in Q1 2020.

HUTCHMED (China) (HCM) Change in Inventory (2020 - 2021) Analysis & Trends

HUTCHMED (China) (HCM) has 2 years of Change in Inventory data on file, last reported at -$64000.0 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -93.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 114.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 119.24 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 40.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 123.00 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -4.30 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 HUTCHMED (China) 241.90 Mn 243.61 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2021 -64,000.00
Mar 31, 2021 -64,000.00
Mar 31, 2020 -436,000.00
Mar 31, 2020 -436,000.00